Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
about
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentAdding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.Drug Repositioning for Effective Prostate Cancer Treatment.Immuno-Oncology: Emerging Targets and Combination TherapiesCombined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
P2860
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@ast
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@en
type
label
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@ast
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@en
prefLabel
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@ast
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@en
P2093
P2860
P356
P1476
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
@en
P2093
Gauthier Bouche
Lydie Meheus
Vidula Sukhatme
Vikas P Sukhatme
P2860
P356
10.3332/ECANCER.2016.610
P577
2016-01-11T00:00:00Z